The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma

Launched by OSLO UNIVERSITY HOSPITAL · Jul 3, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called multi-parametric magnetic resonance imaging (mpMRI) to help doctors better assess penile cancer before surgery. Specifically, it focuses on patients with newly diagnosed penile squamous cell carcinoma (SCC) who may be candidates for organ-sparing surgery (OSS). OSS aims to remove the cancer while preserving as much healthy tissue as possible, which can improve both quality of life and sexual function. However, there is some risk that cancer may return after this type of surgery. The trial will involve 60 patients at Oslo University Hospital to see how effective mpMRI is in accurately staging the cancer and helping doctors decide the best surgical approach.

To be eligible for this trial, participants must be men who have just been diagnosed with penile SCC and are suitable for OSS. They will also need to agree to participate in cancer research. The trial is currently recruiting patients, and those who take part can expect to undergo a non-invasive mpMRI scan, which is a comfortable procedure that does not require any painful interventions. This study is important because it explores a new method that hasn’t been used in standard care yet, potentially leading to better outcomes for men with penile cancer.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • newly diagnosed penile squamous cell carcinoma (SCC)
• • the patient will benefit from organ-sparing surgery (OSS)
• • signed broad consent for cancer research
• Exclusion Criteria:
• • N/A